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Abstract
Background: While vascular and immune abnormalities are common in juvenile and adult dermatomyositis
(DM), the molecular changes that contribute to these abnormalities are not clear. Therefore, we investigated
pathways that facilitate new blood vessel formation and dendritic cell migration in dermatomyositis.
Methods: Muscle biopsies from subjects with DM (9 children and 6 adults) and non-myositis controls (6 children
and 7 adults) were investigated by immunohistochemistry using antibodies that recognize existing (anti-CD146)
and newly formed blood vessels (anti-αVβ3) and mature dendritic cells (anti-DC-LAMP). Blood vessel
quantification was performed by digitalized image analysis. Additional muscle biopsies from subjects with adult DM
and non-myositis controls were used for global gene expression profiling experiments.
Results:  A significant increase in neovascularization was found in muscle biopsies of DM patients;
neovascularization (αVβ3 positive capillaries and vessels per muscle fiber) was much higher in juvenile than in
adult DM patients (control vs juvenile DM: Mean ± SE: 0.06 ± 0.01 vs 0.6 ± 0.05; p < 0.0001 and control vs adult
DM: Mean ± SE: 0.60 ± 0.1 vs 0.75 ± 0.1; p = 0.051). Gene expression analysis demonstrated that genes that
participate not only in angiogenesis but also in leukocyte trafficking and the complement cascade were highly up
regulated in DM muscle in comparison to age matched controls. DC-LAMP positive dendritic cells were highly
enriched at perivascular inflammatory sites in juvenile and adult DM patients along with molecules that facilitate
dendritic cell transmigration and reverse transmigration (CD142 and CD31).
Conclusion: These results suggest active neovascularization and endothelial cell activation in both juvenile and
adult DM. It is likely that close association of monocytes with endothelial cells initiate rapid dendritic cell
maturation and an autoimmune response in DM.
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Background
Idiopathic inflammatory myopathies (polymyositis
(PM); dermatomyositis (DM) and related conditions) are
a heterogenous group of autoimmune disorders whose
causes and pathogenesis remain unclear. In DM, inflam-
matory changes occur both in muscle and in skin.
Although there has been no direct comparison, the path-
ological changes in juvenile and adult DM appear to be
similar except that all the basic pathological features are
more prominent in the childhood form. The main his-
topathologic alterations in DM are found in relation to
the blood vessels of the connective tissue of the muscle,
skin and gastrointestinal tract. In DM, the inflammatory
exudate is predominantly perivascular and perimysial and
to a lesser extent endomysial. In juvenile DM, intramuscu-
lar blood vessels also show endothelial hyperplasia,
immune complex and complement deposition, and focal
loss of capillaries [1]. It is believed that in adult DM, cap-
illary loss precedes other pathological changes in the mus-
cle, and that the capillary endothelium is an early and
possibly primary target of immune attack [2,3]. A physio-
logic reaction to capillary loss would be formation of new
blood vessels, but the evidence for such neovasculariza-
tion in DM patients has not previously been investigated.
The recruitment of leukocytes involves sequential capture
on, rolling along and firm adhesion to the microvascular
endothelium, followed by transmigration of leukocytes
through the vessel wall and further migration in extra-vas-
cular tissue [4]. The steps in the recruitment cascade are
orchestrated by the cell adhesion molecules on both leu-
kocytes and endothelial cells; different subsets of cell
adhesion molecules are responsible for different steps.
Previous studies have shown that adhesion molecules
which facilitate leukocyte transmigration are up-regulated
in the capillaries of DM muscle tissue, suggesting an active
participation in the recruitment of the inflammatory infil-
trate into the muscle tissue [5]. Monocyte-derived den-
dritic cells play a critical role in controlling immunity by
activating naïve T cells. Monocytes leave the blood stream
by endothelial cell transmigration, engulf tissue antigens,
differentiate into mature dendritic cells, and finally
reverse-transmigrate into lymph nodes to activate naïve T-
cells. Recent in vitro studies show that PECAM-1 (CD31)
and tissue factor (CD142) play a critical role in transmi-
gration and reverse transmigration respectively [6,7].
Angiogenesis is an important component of the inflam-
matory response, during which new vessels are formed
from preexisting ones via sprouting and non sprouting
mechanisms. Because the status of angiogenesis in myosi-
tis is not known, we have focused our attention on identi-
fying the molecular processes that facilitate angiogenesis
and the immune response in DM. Our first aim was to
demonstrate whether there are signs of angiogenesis in
muscle tissue of patients with juvenile and adult DM. A
second aim was to identify molecular pathways that are
relevant for angiogenesis by gene expression profiling
using muscle biopsies from adult DM patients, and a third
aim was to investigate whether dendritic cells and mole-
cules that facilitate their entry and exit are present in vivo
in the inflamed muscle tissue of DM patients.
Methods
Patients
All the human tissue samples were handled according to
National Institutes of Health and Johns Hopkins School
of Medicine IRB guidelines. Muscle biopsies from nine
untreated juvenile DM patients (age, years: 6.7 ± 3.2) and
six non-myositis childhood controls (age, years: 11.5 ±
2.9), along with six adult DM patients (age years: 39.4 ±
16.9) and seven normal adult controls (age, years: 37.5 ±
13.9) were used for immunohistochemistry. Myositis
patients met diagnostic criteria of Bohan and Peter [8]. All
adult DM patients had skin rash, muscle weakness, ele-
vated serum levels of muscle enzymes and positive EMG
or a positive muscle biopsy. Histological examination
showed that inflammation was patchy and some muscle
fibers looked apparently normal in some biopsies. It is
not unusual for some muscle fibers in a DM biopsy to
look apparently normal. Muscle biopsies from a separate
group of 5 adult untreated female DM patients (age, years:
48.5 ± 14.8) were profiled and compared to muscle tissue
of normal human muscle (NHM) from four healthy vol-
unteers (age, years: 43.5 ± 12.1). Gene expression profil-
ing was not done on Juvenile DM patients at this time due
to the non availability of muscle tissue suitable for RNA
extractions.
Immunohistochemistry
Immunohistochemistry was performed as described pre-
viously [9]. The cell surface adhesion molecule CD146
has been identified as an endothelial cell marker [10],
whereas the adhesion receptor αVβ3 has been identified
as a marker of angiogenic vascular tissue [11]. We have
used anti-CD146 antibodies as a pan-endothelial marker
to assess all blood vessels and integrin αVβ3 antibodies to
assess new blood vessel formation. The following primary
antibodies were used to detect endothelial cell markers
(mouse anti-human-αVβ3 (1:50) (Chemicon); mouse
anti-human-CD146 (1:60) (Chemicon); anti-human
CD31 (1:20) (Dako); anti-human CD142 (BD Pharmin-
gen); and dendritic cell marker (mouse anti-human DC-
LAMP (1:10) (Immunotech). Anti-mouse HRP (1:500)
(Dako) and anti-rabbit HRP (1:500) (Dako) were used as
secondary and tertiary antibodies. Isotype-matched
mouse Igs and normal rabbit serum were used as negative
controls. Muscle biopsies were serially sectioned (8–10
µm) and stained with CD146 (endothelial) and αVβ3
antibodies. Digital pictures (Axiovision V3.1 software) ofJournal of Autoimmune Diseases 2006, 3:2 http://www.jautoimdis.com/content/3/1/2
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stained sections were taken using a microscope (Axio-
scope, Carl Zeiss). Eight to ten non-overlapping fields
(20X objective) per sample were used for image analysis.
All samples were analyzed independently by two persons
who were blinded to clinical status. The number of blood
vessels or new capillaries per muscle fiber was calculated
for each disease group. Statistical analysis was performed
by Student's t-test.
mRNA profiling
Total RNA was extracted from muscle biopsy or tissue
individually using TRIzol Reagent (Life Technologies,
Gaithersburg, MD). Ten micrograms of each total RNA
sample were processed as previously described [12,13]. A
single cRNA sample from each specimen was applied to
Affymetrix U133A microarrays. Arrays were stained with
phycoerythrin-streptavidin, and the signal intensity was
amplified by treatment with a biotin-conjugated anti-
streptavidin antibody followed by a second stain of phy-
coerythrin-streptavidin. Second-stained arrays were
scanned on a Hewlett-Packard G2500A Gene Array Scan-
ner with the photomultiplier tube set at 1800V.
mRNA profile quality controls and normalization
The profiles were normalized for inter-chip intensity vari-
ation by scaling the overall intensity of each profile to
800, and absolute analysis for each profile was generated
with Affymetrix Microarray Suite 5.0 software. Each pro-
file was subjected to a stringent series of quality controls:
scaling factor <4, present calls >30%, internal probe set
controls 5'/3' ratios >0.6. All profiles passed quality con-
trol measures as described previously [14]. All files associ-
ated with this analysis are available on our web site [15].
All data is also deposited to NCBI GEO, via a custom auto-
mated submission pipeline between the Microarray
Center at Children's National Medical Center and NCBI
GEO. We note that there are a number of alternate meth-
ods for probe set analyses and normalizations for Affyme-
trix arrays (such as ProbeProfiler, dCHIP, RMA), and that
different results can be obtained with different analysis
methods. We have recently shown that an analysis using
MAS 5.0, with a 10% present call filter provides excellent
signal/noise levels for delineation of diagnostic groups in
human muscle biopsies [16], and this is the method used
for the current analysis.
Data analysis
Gene-expression profiles were generated from disease and
control groups using high-density oligonucleotide arrays.
The MAS 5.0 and 10% present call filter was as in our pre-
vious publications [12,17,18]. U133A arrays have about
22,000 probe sets encoding mostly confirmed genes.
Expression changes were initially assessed using Welch's
two sample t test, without correction for multiple testing,
using GeneSpring™ software (Silicon Genetics, Redwood
City, CA). Differentially expressed genes between DM and
NHM were identified by T-test (p < 0.05) and fold change
(greater than 2 fold). Manually grouped genes were fur-
ther clustered with GeneSpring to visualize clusters of
genes with similar expression pattern. Gene tree was
colored by the expression of average over the whole
group. Gene function was based on information available
in public databases or in the literature.
Results
Neoangiogenesis in DM
Blood vessels in normal muscle tissues weakly stained for
CD146, whereas a more intense staining was observed in
capillaries of (endothelial cells and pericytes) adult and
juvenile DM biopsies (Fig. 1). We also have observed
some CD146 non-specific staining on some muscle fibers
of patient biopsies. Capillaries in normal muscle tissues
were generally negative for the neoangiogenesis marker
αVβ3 except for occasionally positive large vessels,
whereas a significant number of capillaries and large
blood vessels were strongly stained for αVβ3 in the adult
and juvenile DM biopsies (Fig. 2). Estimation of the
number of CD146 positive blood vessels (large vessels
and capillaries) per muscle fiber showed no significant
differences between juvenile DM and childhood controls
(control vs JDM: Mean ± SE: 1.0 ± 0.2 vs 1.0 ± 0.3; p = ns);
whereas the number of CD146 positive blood vessels per
Expression pattern of CD146 in juvenile dermatomyositis  (DM), adult DM, and control muscle biopsies Figure 1
Expression pattern of CD146 in juvenile dermatomy-
ositis (DM), adult DM, and control muscle biopsies. 
Frozen muscle sections from myositis and control samples 
were stained with antibodies that recognize pan endothelial 
marker CD146. Representative staining patterns for CD146 
in normal human muscle control (panels a&c) and DM (panel 
b) and juvenile DM (panel d). Note strong endothelial stain-
ing in the capillaries of both DM and juvenile DM patients.
a
c
b
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fiber was significantly reduced in adult DM as compared
to adult controls (control vs DM: Mean ± SE: 2.2 ± 0.3 vs
1.3 ± 0.2; p < 0.05). Estimation of the number of αVβ3
positive blood vessels showed significantly higher
number of αVβ3 positive blood vessels per fiber in the
JDM biopsies compared to the childhood controls (con-
trol vs JDM: Mean ± SE: 0.06 ± 0.01 vs 0.6 ± 0.05; p <
0.0001). In the biopsies from the adult DM patients there
was also an increase in αVβ3 positive blood vessels per
fiber in comparison to adult controls, but this was not sig-
nificant (control vs DM: Mean ± SE: 0.60 ± 0.1 vs 0.75 ±
0.1; p = 0.051).
Angiogenic and anti-angiogenic genes in DM
Because of the evidence of increased angiogenesis in DM,
we next decided to look at the status of genes that influ-
ence the angiogenic pathway by global gene expression
profiling. Gene expression profile analysis of biopsies
from adult DM patients showed that mRNA levels of the
genes that participate in endothelial adhesion (e.g., cathe-
psin B (CTSB), Endo 1-associated antigen (CD146)), pro-
liferation (e.g., cyclin D1), differentiation (e.g., jagged
protein), migration (e.g., hepatocyte growth factor), and
activation (e.g., inositol 1,4,5 trisphosphate receptor type
1 (ITPR1), hypoxia-inducible factor 1 alpha subunit
(HIF1A), toll-like receptor 3, and angiogenic inducer 61)
are up-regulated in DM patients compared to controls.
This suggests that critical molecules required for initiation
of angiogenic response-endothelial cell migration, and
proliferation and maturation of neovasculature, are active
in the DM patients in comparison to controls (Fig. 3).
Whether or not angiogenesis occurs in a particular tissue
depends on the balance between the relative amounts of
pro- and anti-angiogenic factors [19]. Analysis of myositis
and control muscle tissues also showed a significant up
regulation of anti-angiogenic genes (angiopoietin-2, tryp-
tophenyl-tRNA synthetase, interleukin 10 receptor, and
TGF-beta) in DM patients suggesting an active ongoing
anti-angiogenic response (Fig. 3).
The endothelial markers originally identified to be associ-
ated with leukocyte recruitment are also involved in neo-
vascularization, suggesting a dual role not only in
leukocyte-endothelial adhesion but also in angiogenesis
[20]. Significant up-regulation of the markers that partici-
pate in both leukocyte trafficking and angiogenesis (e.g.,
CX3CL1, CCR1, CD47, VCAM-1, ICAM-1, PECAM1 and
ICAM2) is noted in DM patients (Fig. 3).
It has been previously shown that immune complex and
complement deposition occurs in arterioles and capillar-
ies of DM patients [2,21]. Since the complement cascade
is intricately associated not only with vessel damage but
also with angiogenesis, we have specifically looked for
members of the complement cascade that facilitate angio-
genesis. We found that both classical and alternate com-
plement cascade members along with regulators (Factor-
B, C7, Factor-I, C1S, Factor H, and C4) are highly up reg-
ulated in DM patients (Fig. 3).
DC-LAMP positive dendritic cells in DM
Gene expression analysis of adult DM samples clearly
showed that both PECAM1 and tissue factor are highly
upregulated in these patients as are several dendritic cell/
macrophage maturation markers (FLT3 ligand, CD68,
CD11B, DC-LAMP, HLA-DQ, HLA-DRB, and B7-2) (data
not shown). We have confirmed the presence of DC-
LAMP positive dendritic cells at the perivascular inflam-
matory sites, often in close proximity to blood vessels in
myositis patients (Fig. 4). Immunohistochemical analysis
also suggests that the genes that facilitate the transmigra-
tion and reverse transmigration (CD31 and CD142) of
dendritic cells are upregulated in blood vessels of both
juvenile (Fig. 5 upper panels) and adult DM patients (data
not shown) and DC-LAMP positive dendritic cells in close
proximity to CD31 positive blood vessels (Fig. 5 lower
panels). We found modest blood vessel staining for both
CD 31 and CD 142 in control biopsies (data not shown).
Discussion
Immunohistochemical and global gene expression analy-
sis of independent groups of DM muscle samples clearly
Expression pattern of αVβ3 in juvenile DM, adult DM, and  control muscle biopsies Figure 2
Expression pattern of αVβ3 in juvenile DM, adult DM, 
and control muscle biopsies. Frozen muscle sections 
from myositis and normal human muscle control samples 
were stained with antibodies that recognize αVβ3. Repre-
sentative staining patterns for αVβ3 in control (panels a&c) 
and DM (panel b) and juvenile DM (panel d).Journal of Autoimmune Diseases 2006, 3:2 http://www.jautoimdis.com/content/3/1/2
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showed that angiogenesis and genes that influence angio-
genesis, leukocyte migration, and complement activation
are highly upregulated in DM. Expression profiling also
suggested that several dendritic cell markers are up-regu-
lated in DM patients. We have confirmed the presence of
DC-LAMP positive dendritic cells that are predominantly
localized in perivascular areas of inflammation and in
close proximity to blood vessels. Juvenile and adult DM
patients also had dendritic cells in close proximity to
blood vessels expressing antigens (e.g., PECAM and Tissue
factor) that facilitate their transmigration and reverse
transmigration.
It is known that skeletal muscle capillarity is very
dynamic, for example repeated exercise results in
increased capillarity and inactivity results in reduced cap-
Members of the angiogenic, anti-angiogenic, lymphocyte trafficking and complement activation pathways are highly up-regulated  in DM patients compared to normal human muscle (NHM) controls Figure 3
Members of the angiogenic, anti-angiogenic, lymphocyte trafficking and complement activation pathways are 
highly up-regulated in DM patients compared to normal human muscle (NHM) controls. Gene-expression profiles 
generated from disease and control groups were analyzed using high-density oligonucleotide arrays. Gene expression values 
were obtained following Affymetrix MAS5 normalization. Manually grouped genes were further clustered with GeneSpring to 
visualize clusters of genes with similar expression pattern. Gene tree was colored by the expression of average over the whole 
group. Gene function was based on information available in public databases or in the literature.
2
C
2
A
2
I
2
C
2
F
2
T
2
H
2
C
2
B
2
H
cathepsin B
jagged 1
Type 1 inositol 1,4,5-triphosphate receptor
CD146
fibronectin 1
toll-like receptor 3
hypoxia-inducible factor 1
angiogenic inducer, 61
cyclin D1
hepatocyte growth factor
tryptophanyl-tRNA synthetase
chemokine (C-X-C motif) ligand 9
tissue inhibitor of metalloproteinase 2
chemokine (C-X-C motif) ligand 10
transforming growth factor  beta
angiopoietin 2
interleukin 10 receptor, alpha
chemokine (C-X-C motif) ligand 11
complement component 1  s
H factor 1
complement component 3a receptor 1
B-factor
complement component 4
complement component 7
H factor (complement)-like 1
chemokine (C-C motif) receptor 1
intercellular adhesion molecule 2
chemokine (C-X3-C motif) ligand 1
CD47 antigen
vascular cell adhesion molecule 1
platelet/endothelial cell adhesion molecule
A
n
g
i
o
g
e
n
e
s
i
s
A
n
g
i
o
g
e
n
i
c
i
n
h
i
b
i
t
o
r
s
L
e
u
k
o
c
y
t
e
t
r
a
f
f
i
c
k
i
n
g
C
o
m
p
l
e
m
e
n
t
p
a
t
h
w
a
y
NHM DMJournal of Autoimmune Diseases 2006, 3:2 http://www.jautoimdis.com/content/3/1/2
Page 6 of 8
(page number not for citation purposes)
illarity [22]. There is little information, however, regard-
ing the molecular pathways that influence capillary
formation in inflammatory muscle diseases. Angiogenesis
is generally quiescent in adults with the exception of cer-
tain tightly controlled physiological situations such as
female reproductive functions and tissue regeneration and
repair [23]. It is widely accepted that the "angiogenic
switch" is 'off' when the effect of pro-angiogenic mole-
cules is balanced by that of anti-angiogenic molecules and
is 'on' when the net balance is tipped in favor of angiogen-
esis [24]. The relative contributions of both pro- and anti-
angiogenic factors are likely to change the vascular net-
work in a diseased tissue. Although the exact mechanisms
controlling angiogenesis in inflamed muscle are not fully
understood, mechanistically, the major stimuli for neo-
vascularization are hypoxia and inflammation. Inflamma-
tory signals recruit lymphocytes and macrophages into
areas of neovascularization which further act as a source
of angiogenic and arteriogenic factors.
It has been previously shown that there is significant cap-
illary loss in the muscle of adult DM patients associated
with deposition of the late components of the comple-
ment pathway [21]. Our current findings using CD 146
antibodies support and confirm the previous results in
adult DM. It was also suggested that similar loss of capil-
laries occur in juvenile DM patients, but there have been
no systematic quantitative studies addressing the capillary
loss in juvenile DM patients. Our data in juvenile DM
patients in comparison with childhood non-inflamma-
tory myopathic controls suggest that there is no significant
net capillary loss despite activated complement system in
juvenile DM patients. These results suggest that either cap-
illary loss is effectively compensated by robust new capil-
lary formation or complement mediated damage is
modest. In adult DM the number of αVβ3 positive (new)
capillaries is not significantly different from that of con-
trols. The modest increase in new capillaries in adult DM
also suggests ongoing loss of existing capillaries. Our find-
ings further confirm and extend previously published
gene expression data as well as the recent studies showing
up-regulation of angiogenesis-related factors (HIF-1beta,
alphaV beta3, VEGFR-1) in DM biopsies [25,26]
Although previous work has shown a decrease in capillar-
ies in DM but not PM, our results suggest that there is a
significant upregulation of several pathways that initiate
angiogenesis in myositis. The new capillaries are highly
significantly increased in JDM in comparison with respec-
tive controls. Thus it appears that the association between
myositis lesions and neovascularization is not merely an
epiphenomenon, but represents a compensatory mecha-
Expression pattern of CD142, CD31 and DC-LAMP in juve- nile DM patients Figure 5
Expression pattern of CD142, CD31 and DC-LAMP 
in juvenile DM patients. Serial sections of juvenile DM 
biopsies stained with anti-tissue factor (CD142) and 
PECAM1 (CD31) antibodies (upper panel). Serial sections 
stained with CD31 and DC-LAMP showing close proximity 
of DC-LAMP positive cells to CD31 positive blood vessels 
(arrows).
CD31 DC-LAMP
CD142 CD31
DC-LAMP positive dendritic cells are enriched in perivascu- lar area of inflammation in juvenile DM patients Figure 4
DC-LAMP positive dendritic cells are enriched in 
perivascular area of inflammation in juvenile DM 
patients. Juvenile DM and control biopsies were stained 
with antibodies that recognize dendritic cell marker DC-
LAMP along with an isotype matched control (upper panels). 
Consecutive sections stained with DC-LAMP and CD146 
showing close proximity of DC-LAMP positive cells to blood 
vessels. Normal biopsies showed no staining with DC-LAMP 
antibodies (data not shown).
Isotype
DC-LAMP CD146
DC-LAMPJournal of Autoimmune Diseases 2006, 3:2 http://www.jautoimdis.com/content/3/1/2
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nism. In this study all adult DM patients were used for
immunohistochemical analysis were treated with Pred-
nisone. The differences in angiogenic responses between
juvenile and adult DM patients are likely not due to the
medication, because gene expression profiling of
untreated adult DM patients also show up-regulated ang-
iogenic genes.
Pathological conditions, such as the inflammatory proc-
ess, may perturb the resting state of the endothelial cells
and promote transendothelial migration of cells and leak-
age of molecules that are needed at specific sites. Leuko-
cyte interactions with inflamed endothelial cells are
mediated by selectins, signaling molecules that include
lipids and chemokines, integrins and their ligands, and
junctional molecules. Several of these molecules that were
initially identified to have a role in leukocyte trafficking
have also been found to influence endothelial cell activa-
tion, proliferation and differentiation. For example, dif-
ferent complement activation products can perturb the
antithrombotic state of quiescent endothelial cells by var-
ious mechanisms for example C5a causes the release of
heparin sulfate from endothelial cells, and the membrane
attack complex is now widely recognized as a potent pro-
moter of coagulation [27]. The membrane attack complex
added to endothelial cells in sublytic concentrations
induces release of von Willebrand Factor, which in turn
favors platelet adherence to the vessel wall [28], and pro-
motes the assembly of prothrombinase by the exposure of
phospholipids [29].
Dendritic cells are antigen presenting cells with the
unique ability to initiate an immune response. Immature
dendritic cells are localized in peripheral tissues where
they exert a sentinel function for incoming antigens. After
antigen capture and exposure to inflammatory stimuli,
dendritic cells undergo maturation and migrate to
regional lymph nodes where the presentation of antigenic
peptides to T lymphocytes takes place. It is known that
some monocytes differentiate into dendritic cells in
response to cues that are endogenous to endothelial cells
[6,30]. Passage of leukocytes across the endothelial lining
into sites of inflammation has been shown to be regulated
largely by platelet/endothelial cell adhesion molecule-1
(PECAM/CD31) and the reverse transmigration involves
p-glycoprotein and tissue factor expressed on the leuko-
cytes. The reverse transmigrating cells were shown to be
dendritic cells [6]. Both tissue factor and PECAM are
highly significantly expressed DM patients suggesting an
active participation in dendritic cell migration.
Conclusion
In summary, these results suggest that neoangiogenesis is
highly activated in DM patients. It appears that significant
new blood vessel formation in patients is influenced not
only by traditional pro-and anti-angiogenic genes, but
also by genes that participate in leukocyte trafficking and
complement activation pathways. Further it is likely that
close association of monocytes with activated endothelial
cells will initiate rapid dendritic cell maturation and initi-
ation of autoimmune response in DM.
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